Search

Your search keyword '"Biotechnology -- Health aspects"' showing total 1,563 results
Start Over Descriptor "Biotechnology -- Health aspects"
1,563 results on '"Biotechnology -- Health aspects"'

1. European Biotech Targeting Anti-ageing: Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process

Author

Barton, Cheryl

Subjects
Biotechnology -- Health aspects, Gene therapy -- Health aspects, Drug approval -- Health aspects, Business, Pharmaceuticals and cosmetics industries
Abstract

Over the past century, life expectancy has dramatically increased in most parts of the world, but humans are spending more years in poor health than at any point in history [...]

Published
2024

2. Data on Obesity, Fitness and Wellness Described by Researchers at National Institute of Biotechnology and Genetics Engineering (Antipathogenic and Probiotic Potential of Enterococci Found In the Entrails of the Palmetto Bug)

Subjects
Biotechnology -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2024 NOV 16 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Obesity, Fitness and Wellness have been published. According [...]

Published
2024

3. Data on Alzheimer Disease Reported by Researchers at Department of Biotechnologies (Mechanistic and Therapeutic Role of Nlrp3 Inflammasome In the Pathogenesis of Alzheimer's Disease)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Diseases -- India, Biotechnology -- Health aspects, Biotechnology industry -- Health aspects, Alzheimer's disease -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2024 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Neurodegenerative Diseases and Conditions - Alzheimer Disease. [...]

Published
2024

4. Matica Biotechnology Enters CDMO Partnership with KaliVir Immunotherapeutics

Subjects
Biotechnology -- Health aspects, Biotechnology industry -- Alliances and partnerships, Arts and entertainment industries
Abstract

Matica Biotechnology, a CDMO specializing in viral vector development and manufacturing, reported the signing of a Letter of Intent (LOI) with KaliVir Immunotherapeutics, a U.S.-based clinical-stage biotechnology company developing, multi-mechanistic [...]

Published
2024

5. Kane Biotech inks agreement with XSONX to distribute wound hygiene system in Canada, Australia, New Zealand & GCC countries

Subjects
Hygiene -- Health aspects, Biotechnology -- Health aspects, Biotechnology industry -- Distribution agreements, Pharmaceuticals and cosmetics industries, Cooperation Council for the Arab States of the Gulf -- Distribution agreements
Abstract

Kane Biotech Inc, a biotechnology company engaged in the research, development and commercialization of technologies and products to prevent and remove microbial biofilms, announced that it has signed an exclusive [...]

Published
2024

6. Milestone Approval to Steady Stream, Gene Editing Revs Up: The milestone approval of a gene-edited therapeutic paves the way for gene-editing technologies

Author

Mirasol, Feliza

Subjects
Biological products industry -- Health aspects, Independent regulatory commissions -- Health aspects, Genes -- Health aspects, Biotechnology -- Health aspects, Messenger RNA -- Health aspects, Vaccines -- Health aspects, Biotechnology industry, Business, Pharmaceuticals and cosmetics industries
Abstract

With the rise of nucleic acid-based therapeutics, such as the mRNA vaccines, biopharma developers are working toward the next big breakthrough in personalized medicines. Over the past couple of years, [...]

Published
2024

7. Unlock the Full Potential of Cell and Gene Therapies: The 2024 GenScript Biotech Global Forum Heads to London

Subjects
Capital gains tax -- Health aspects, T cells -- Health aspects, Genes -- Health aspects, Biotechnology -- Health aspects, Gene therapy -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2024 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- The cell and gene therapy (CGT) industry has witnessed remarkable growth in [...]

Published
2024

8. Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancer (Updated August 26, 2024)

Subjects
Biotechnology -- Health aspects, Cancer -- Care and treatment, Breast cancer -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2024 SEP 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2024

9. Philly biotech to deliver first-of-its-kind cancer therapy

Subjects
Hurricane Helene, 2024 -- Health aspects, Drugs -- Overdose, Antineoplastic agents -- Health aspects, Biotechnology -- Health aspects, Cancer -- Care and treatment -- Health aspects, Whooping-cough -- Health aspects, Antimitotic agents -- Health aspects, Business, General interest, Business, regional
Abstract

Byline: Aubrey Whelan Oct. 9Good morning. Today, we have an inside look at a Philly biotech that's gearing up to make its first doses of a groundbreaking treatment for a [...]

Published
2024

10. A Philadelphia biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients

Subjects
Biotechnology -- Health aspects, Cancer -- Care and treatment, Drug approval -- Health aspects, Business, General interest, Business, regional, Tecelra (Medication) -- Health aspects
Abstract

Byline: Alison McCook PHILADELPHIA Within the next couple of weeks, the first blood samples from patients will arrive at the loading dock of Adaptimmune, a biotechnology company headquartered on the [...]

Published
2024

11. A Navy Yard biotech designed a first-of-its-kind therapy for rare cancer. Now, it waits for patients

Subjects
Biotechnology -- Health aspects, Cancer -- Care and treatment, Drug approval -- Health aspects, Business, General interest, Business, regional, Tecelra (Medication) -- Health aspects
Abstract

Byline: Alison McCook Oct. 8Within the next couple of weeks, the first blood samples from patients will arrive at the loading dock of Adaptimmune, a biotechnology company headquartered on the [...]

Published
2024

12. MAIA Biotechnology announces recent clinical progress for novel anticancer agent

Subjects
Biotechnology -- Health aspects, Biotechnology industry -- Health aspects, Immunotherapy -- Health aspects, Cancer -- Care and treatment, Lung cancer, Non-small cell -- Drug therapy, Pharmaceuticals and cosmetics industries
Abstract

MAIA Biotechnology Inc, a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, announced the highlights and key achievements year-to-date, including recent clinical progress for lead candidate THIO, a potential first-in-class [...]

Published
2024

13. Findings from Biotechnology Laboratory in Obesity, Fitness and Wellness Reported (Efficient H2o2-sonochemical Treatment of Penicillin G In Water: Optimization, Di-hrms Ultra-trace By-products Analysis, and Degradation Pathways)

Subjects
Penicillin G -- Health aspects, Biotechnology -- Health aspects, Hydrogen peroxide -- Health aspects, Antibiotics -- Health aspects, Physical fitness -- Health aspects, Health
Abstract

2024 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in Obesity, Fitness and Wellness. According to news [...]

Published
2024

14. Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Subjects
United States. Centers for Disease Control and Prevention, Trinity Biotech PLC -- Investments, Medical tests -- Health aspects, Diabetes therapy -- Health aspects, Biotechnology -- Health aspects, Biotechnology industry -- Health aspects -- Investments, Infection -- Health aspects, Company investment, General interest, News, opinion and commentary
Abstract

DUBLIN: Trinity Biotech plc has issued the following press release: Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, [...]

Published
2024

15. Matica Biotechnology Establishes CDMO Partnership with KaliVir Immunotherapeutics

Subjects
Biotechnology -- Health aspects, Biotechnology industry -- Alliances and partnerships, Immunotherapy -- Health aspects, Business, Business, international
Abstract

COLLEGE STATION, Texas -- Matica Biotechnology Inc. (Matica Bio), a CDMO specializing in viral vector development and manufacturing, announced the signing of a Letter of Intent (LOI) with KaliVir Immunotherapeutics, [...]

Published
2024

16. ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR(TM) Trial for Myotonic Dystrophy Type 1 (DM1)

Subjects
Gene expression -- Health aspects, Biotechnology -- Health aspects, MicroRNA -- Health aspects, Myotonic dystrophy -- Health aspects, Business, News, opinion and commentary
Abstract

-ATX-01 is the industry's first anti-microRNA therapeutic to be investigated in DM1 -- VALENCIA, Spain, Oct. 18, 2024 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing [...]

Published
2024

18. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Therapeutic Vaccine Clinical Trial Linkage Support Project (3Rd Year)_Equipment (Cold Injection Water Device) Purchase

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Biotechnology -- Health aspects, Vaccines -- Product development, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Therapeutic Vaccine Clinical Trial Linkage Support Project (3Rd Year)_Equipment (Cold Injection Water Device) Purchase. Tender Notice No: 20240818547-00 [...]

Published
2024

20. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Therapeutic Vaccine Clinical Trial Linkage Support Project (3Rd Year)_Purchase of Equipment (Filter Tester)

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Biotechnology -- Health aspects, Vaccines -- Product development, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Therapeutic Vaccine Clinical Trial Linkage Support Project (3Rd Year)_Purchase of Equipment (Filter Tester). Tender Notice No: 20240735559-00 Deadline: [...]

Published
2024

21. HEALTH AND HUMAN SERVICES, DEPARTMENT OF invites tenders for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological Related Disorders

Subjects
Social service -- Health aspects, Biological products -- Health aspects, Biotechnology -- Health aspects, News, opinion and commentary
Abstract

HEALTH AND HUMAN SERVICES, DEPARTMENT OF, United States has invited tenders for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological Related Disorders. Tender [...]

Published
2024

22. ARTHEx Biotech gets US FDA clearance to begin phase I-IIa ArthemiR trial of ATX-01 for myotonic dystrophy type 1

Subjects
United States. Food and Drug Administration, Biotechnology -- Health aspects, Biotechnology industry -- Product development, MicroRNA -- Health aspects, Myotonic dystrophy -- Care and treatment, Pharmaceuticals and cosmetics industries
Abstract

ARTHEx Biotech S.L., a clinical-stage biotechnology company, announced that the US Food and Drug Administration (FDA) cleared the company to initiate the phase I-IIa ArthemiR study of ATX-01 for the [...]

Published
2024

23. Homologous recombination deficiency and tumor suppressor heterozygosity mediate resistance to front-line therapy in breast cancer

Subjects
Women -- Health aspects, Biotechnology -- Health aspects, Cancer -- Care and treatment, Breast cancer -- Health aspects, Health, Women's issues/gender studies
Abstract

2024 FEB 29 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2024

24. Reports Outline Biotechnology Findings from Chinese Academy of Sciences (Identification and Characterization of a Novel Haematococcus Pluvialis Strain Resistant To Paraphysoderma Sedebokerense Infection)

Subjects
Chinese Academy of Sciences, Health aspects, Biotechnology -- Health aspects
Abstract

2024 DEC 11 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Current study results on Biotechnology have been published. According to news reporting originating from Wuhan, [...]

Published
2024

25. Data from Guangdong Medical University Advance Knowledge in Osteoporosis (Advances In the Study of Metal-organic Frameworks and Their Biomolecule Composites for Osteoporosis Therapeutic Applications)

Subjects
Biochemistry -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Osteoporosis -- Health aspects, Biotechnology -- Health aspects
Abstract

2024 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Musculoskeletal Diseases and Conditions - Osteoporosis have been published. [...]

Published
2024

26. New Biotechnology Findings from Osaka University Described (Infection-prevention Performance of Local Exhaust Ventilation Under Three Different Underfloor Air Distribution Systems During a Face-to-face Conversation)

Subjects
Prevention, Health aspects, Biotechnology -- Health aspects, Medical research -- Health aspects, Infection -- Prevention, Medicine, Experimental -- Health aspects
Abstract

2024 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- Investigators discuss new findings in Biotechnology. According to news reporting originating in Osaka, Japan, by [...]

Published
2024

27. Matica Biotechnology Enters CDMO Partnership with KaliVir Immunotherapeutics

Subjects
Biotechnology -- Health aspects, Biotechnology industry -- Alliances and partnerships, Business, Business, international, Telecommunications industry
Abstract

Matica Biotechnology, a CDMO specializing in viral vector development and manufacturing, reported the signing of a Letter of Intent (LOI) with KaliVir Immunotherapeutics, a U.S.-based clinical-stage biotechnology company developing, multi-mechanistic [...]

Published
2024

28. Purple Biotech Reports Additional Positive Interim Data from its Randomized Phase 2 Study with its Lead Oncology Therapeutic Candidate CM24

Subjects
Oncology, Experimental -- Health aspects, Biotechnology -- Health aspects, Chemotherapy -- Health aspects, Cancer -- Chemotherapy -- Research, Pancreatic cancer -- Health aspects, General interest, News, opinion and commentary
Abstract

REHOVOT: Purple Biotech Ltd. has issued the following news release: Purple Biotech Ltd. ('Purple Biotech' or 'the Company') (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune [...]

Published
2024

29. IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer

Subjects
Biotechnology -- Health aspects, Squamous cell carcinoma -- Care and treatment, Clinical trials -- Health aspects, Vaccines -- Product development, Banking, finance and accounting industries, Business
Abstract

-- Study Meets Overall Response Rate Primary Endpoint, Encouraging Secondary Endpoint Progression-Free Survival Data in Squamous Cell Carcinoma of the Head and Neck Cohort -- -- No New Safety Signals [...]

Published
2024

30. Orveda, the French multi-award-winning biotech skincare brand, unveils LA MAISON ORVEDA NEW YORK CITY, a wellness sanctuary dedicated to glow and skin longevity, located in the heart of the Upper East Side

Subjects
Biotechnology -- Health aspects, Toiletries industry -- Achievements and awards, Skin -- Health aspects, Business, Business, international
Abstract

NEW YORK -- Orveda, the award-winning French biotech skincare brand, is delighted to announce the opening of its first flagship boutique in the United States, La Maison Orveda New York [...]

Published
2024

31. IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA(R) (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma

Subjects
Biotechnology -- Health aspects, Cancer vaccines -- Product development, Melanoma -- Care and treatment, Banking, finance and accounting industries, Business, Keytruda (Medication) -- Product development -- Health aspects
Abstract

- Based on a per-protocol interim analysis of safety and efficacy data, the Independent Data Monitoring Committee (IDMC) recommended that the trial continue without modifications - No new safety signals [...]

Published
2024

32. Excision BioTherapeutics Awarded a 'Fierce 15' Biotech Company of 2024

Subjects
Blindness -- Health aspects, Biotechnology -- Health aspects, Biotechnology industry -- Health aspects, Banking, finance and accounting industries, Business
Abstract

Company Applying its Proprietary CRISPR Technology to Address Recurrent Infections in Herpes Simplex Keratitis (HSK) HSK is the Leading Cause of Corneal Blindness in the United States, With an Estimated [...]

Published
2024

33. Vir Biotechnology Acts on Expanded Strategy of Powering the Immune System Through Exclusive Worldwide License Agreement with Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-cell Engagers

Subjects
Sanofi S.A. -- Licensing agreements, T cells -- Health aspects, Biotechnology -- Health aspects, Cells -- Health aspects, Pharmaceutical industry -- Licensing agreements, Company licensing agreement, Business, Business, international
Abstract

- Bolsters clinical pipeline and adds near-term value creation opportunities - - Licenses proprietary masking platform with goal of minimizing off-tumor toxicity and offering expanded therapeutic index in patients - [...]

Published
2024

34. Hepatitis B Virus Infection Pipeline 2024 | Vir Biotechnology, Arbutus Biopharma, Nucorion Pharmaceuticals, Xian Xintong Pharmaceutical Research, Dong-A ST Co. Ltd., Gilead Sciences

Subjects
Gilead Sciences Inc., Biological products industry -- Health aspects, Biotechnology -- Health aspects, Infection -- Health aspects, Hepatitis B -- Health aspects, Hepatitis B virus -- Health aspects, Business, Business, international
Abstract

M2 PRESSWIRE-July 12, 2024-: Hepatitis B Virus Infection Pipeline 2024 | Vir Biotechnology, Arbutus Biopharma, Nucorion Pharmaceuticals, Xian Xintong Pharmaceutical Research, Dong-A ST Co. Ltd., Gilead Sciences (C)1994-2024 M2 COMMUNICATIONS [...]

Published
2024

35. Biotech company Eradivir is developing lead drug EV25 to treat influenza

Subjects
Biotechnology -- Health aspects, Biotechnology industry -- Health aspects, Immunotherapy -- Health aspects, Influenza -- Drug therapy, Business, international
Abstract

(GLOBE NEWSWIRE via COMTEX) -- Company has completed the required preclinical studies and will seek regulatory approval to dose volunteers in Belgium by the end of the year WEST LAFAYETTE, [...]

Published
2024

36. Manufacturing And Nonclinical Studies Support For The Development Of Therapeutic Biotechnology Products (biologics) For Neurological Related Disorders

Subjects
United States. National Institutes of Health, Nervous system diseases -- Health aspects, Biological products -- Health aspects, Biotechnology -- Health aspects, Drug discovery -- Health aspects, Business, international, Health aspects
Abstract

Solicitation (original): manufacturing and nonclinical studies support for the development of therapeutic biotechnology products (biologics) for neurological related disorders the national institutes of neurological disorders and stroke (ninds) has a [...]

Published
2024

37. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Purchase of Ultra-Low Temperature Freezer for Therapeutic Vaccine Clinical Trial Linkage Support Project

Subjects
Biotechnology -- Health aspects, Vaccines -- Product development, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Purchase of Ultra-Low Temperature Freezer for Therapeutic Vaccine Clinical Trial Linkage Support Project. Tender Notice No: 20240637958-00 Deadline: [...]

Published
2024

38. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Purchase of Incubator for Therapeutic Vaccine Clinical Trial Linkage Support Project

Subjects
Biotechnology -- Health aspects, Vaccines -- Product development, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Purchase of Incubator for Therapeutic Vaccine Clinical Trial Linkage Support Project. Tender Notice No: 20240637906-00 Deadline: July 8, [...]

Published
2024

39. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Purchase of Co2 Incubator for Therapeutic Vaccine Clinical Trial Linkage Support Project

Subjects
Biotechnology -- Health aspects, Vaccines -- Product development, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Purchase of Co2 Incubator for Therapeutic Vaccine Clinical Trial Linkage Support Project. Tender Notice No: 20240638375-00 Deadline: July [...]

Published
2024

40. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Purchase of Refrigerator for Therapeutic Vaccine Clinical Trial Linkage Support Project

Subjects
Biotechnology -- Health aspects, Vaccines -- Product development, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Purchase of Refrigerator for Therapeutic Vaccine Clinical Trial Linkage Support Project. Tender Notice No: 20240638343-00 Deadline: July 8, [...]

Published
2024

41. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Purchase of Large Refrigerator for Therapeutic Vaccine Clinical Trial Linkage Support Project

Subjects
Biotechnology -- Health aspects, Vaccines -- Product development, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Purchase of Large Refrigerator for Therapeutic Vaccine Clinical Trial Linkage Support Project. Tender Notice No: 20240638360-00 Deadline: July [...]

Published
2024

43. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Smart Characterization Base Construction Project_Therapeutic Vaccine_3Rd Year_Chromatography System

Subjects
Chromatography -- Health aspects, Biotechnology -- Health aspects, Vaccines -- Health aspects, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Smart Characterization Base Construction Project_Therapeutic Vaccine_3Rd Year_Chromatography System. Tender Notice No: 20240627198-00 Deadline: July 2, 2024 Copyright © [...]

Published
2024

44. JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER invites tenders for Smart Specialization Base Construction Project_Therapeutic Vaccine_3Rd Year_Automatic Vial Charger

Subjects
Biotechnology -- Health aspects, Vaccines -- Health aspects, News, opinion and commentary
Abstract

JEONNAM BIOTECHNOLOGY AGENCY BIOPHARMACEUTICAL RESEARCH CENTER, South Korea has invited tenders for Smart Specialization Base Construction Project_Therapeutic Vaccine_3Rd Year_Automatic Vial Charger. 20240539261-00 Deadline: June 14, 2024 Copyright © 2011-2022 pivotalsources.com. [...]

Published
2024

45. Study Results from Biotechnology Research Center Update Understanding of Hepatitis C Virus (Hepatitis C Virus May Accelerate Breast Cancer Progression By Increasing Mutant P53 and C-myc Oncoproteins Circulating Levels)

Subjects
Oncology, Experimental -- Health aspects, Tumor proteins -- Development and progression, Biotechnology -- Health aspects, Hepatitis C virus -- Health aspects, Cancer -- Research, Breast cancer -- Development and progression, Physical fitness -- Health aspects, Health
Abstract

2023 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Liver Diseases and Conditions - Hepatitis C [...]

Published
2023

46. Edesa Biotech announces Health Canada approval of updated trial design

Subjects
Biotechnology -- Health aspects, Clinical trials -- Health aspects, Monoclonal antibodies -- Health aspects, Acute respiratory distress syndrome -- Health aspects, Business, News, opinion and commentary
Abstract

Edesa Biotech announced that Health Canada has approved the company's proposal to harmonize clinical trial designs in the U.S. and Canada for an ongoing Phase 3 study of EB05. Edesa's [...]

Published
2023

47. Preventing Catastrophic Bioterrorism: Guarding Against Exploitation of the Life Sciences and Biotechnology

Author

Yassif, Jaime

Subjects
Bioterrorism -- Health aspects, Epidemics -- Health aspects, Biotechnology -- Health aspects, Biological weapons -- Health aspects, Military and naval science
Abstract

Bioscience and biotechnology advances offer extraordinary promise, but they are also accompanied by emerging biological risks--specifically the potential for catastrophic accidents or deliberate misuse by malicious actors seeking to cause harm. These risks include the possibility that non-state actors could exploit the legitimate global bioscience research and development enterprise to gain the knowledge and materials to develop and disseminate a biological weapon. We must take action to safeguard the life sciences to prevent biotechnology catastrophe, in addition to bolstering law enforcement and intelligence capabilities to more effectively anticipate and prevent bioterrorism and other biological threats., The COVID-19 pandemic has revealed that countries around the world are woefully unprepared to prevent and respond to pandemics. The SARS-CoV-2 virus has infected more than 520 million people, killed [...]

Published
2022

48. Gene-Editing Biotech Prime Medicine Strikes Up Cell Therapy R&D Alliance With Bristol Myers Squibb

Author

Vinluan, Frank

Subjects
T cells -- Health aspects, Biotechnology -- Health aspects
Abstract

https://medcitynews.com/2024/09/gene-editing-prime-editing-medicine-cell-therapy-cancer-immunology-bristol-myers-squibb/ Bristol Myers Squibb is turning to the prime-editing technology of Prime Medicines for the R&D of new cell therapies for cancer and immunology. The pharma giant is paying $110 [...]

Published
2024

49. Studies from National Institute of Animal Biotechnology in the Area of COVID-19 Described (Unveiling the Potential: High-affinity Aptamers for Point of Care Detection of Sars-cov-2 Rbd Protein and It's Validation In Clinical Samples)

Subjects
Biotechnology -- Health aspects, Coronaviruses -- Health aspects, Business, Health, Health care industry, Health aspects
Abstract

2024 AUG 11 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Data detailed on Coronavirus - COVID-19 have been presented. According [...]

Published
2024

50. Vir Biotechnology Received FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection

Subjects
United States. Food and Drug Administration, Hepatitis -- Drug therapy, Biotechnology -- Health aspects, Infection -- Drug therapy, Clinical trials -- Health aspects, Monoclonal antibodies -- Health aspects, General interest, News, opinion and commentary
Abstract

SAN FRANCISCO: Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application and granted Fast Track designation [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results